Archive

2023

  |  

Navier moves into a new HQ and begins to build its culture while also progressing with technical development and marketing approvals of its first product, Mosaic....

Read More

2022

  |  

Otto joins the company as Executive Chairman, Sander commences as CEO and Barry resigns from UWA and becomes CTO. Navier Medical is awarded the ‘Most Outstanding Patient Innovation’ by the Australian Patients Association....

Read More

2021

  |  

Barry founds Navier Medical Limited and the company spins out of the university system. Otto Buttula takes a stake in the company, and Barry connects with Sander Bangma. Lachlan joins Navier Medical full-time and the company wins the WA Innovator of the Year Award in...

Read More

2020

  |  

A voice of customer study is performed with Curve Tomorrow and further de-risking is performed through ANDHealth workshops....

Read More

2019

  |  

Lachlan completes his PhD and UWA provides Barry with funding to explore commercialization. De-risking activities are performed with the product development company Planet Innovation....

Read More

2018

  |  

Project results are encouraging and efforts begin to commercialize the technology, with help from Dr Sam South at UWA....

Read More

2014

  |  

Barry collaborates with Prof Carl Schultz, a cardiologist at UWA and the Royal Perth Hospital, on coronary artery disease. Lachlan Kelsey begins his PhD on the project....

Read More

2013

  |  

The Vascular Engineering Lab (VascLab) is established by A/Prof Barry Doyle, a biomedical engineer at UWA, with a focus on using engineering to better understand heart disease....

Read More

2016

  |  

VascLab moves to the Harry Perkins Institute of Medical Research and the lab’s focus on medical devices to treat heart disease begins to accelerate....

Read More